119 related articles for article (PubMed ID: 19780183)
1. Hyperpolarized (13)C magnetic resonance detection of carboxypeptidase G2 activity.
Jamin Y; Gabellieri C; Smyth L; Reynolds S; Robinson SP; Springer CJ; Leach MO; Payne GS; Eykyn TR
Magn Reson Med; 2009 Nov; 62(5):1300-4. PubMed ID: 19780183
[TBL] [Abstract][Full Text] [Related]
2. A novel technique to monitor carboxypeptidase G2 expression in suicide gene therapy using 19F magnetic resonance spectroscopy.
Mancini L; Davies L; Friedlos F; Falck-Miniotis M; Dzik-Jurasz AS; Springer CJ; Leach MO; Payne GS
NMR Biomed; 2009 Jun; 22(5):561-6. PubMed ID: 19259950
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive detection of carboxypeptidase G2 activity in vivo.
Jamin Y; Smyth L; Robinson SP; Poon ES; Eykyn TR; Springer CJ; Leach MO; Payne GS
NMR Biomed; 2011 May; 24(4):343-50. PubMed ID: 20891022
[TBL] [Abstract][Full Text] [Related]
4. Detection of the prodrug-activating enzyme carboxypeptidase G2 activity with chemical exchange saturation transfer magnetic resonance.
Jamin Y; Eykyn TR; Poon E; Springer CJ; Robinson SP
Mol Imaging Biol; 2014 Apr; 16(2):152-7. PubMed ID: 23955100
[TBL] [Abstract][Full Text] [Related]
5. Gene-directed enzyme prodrug therapy with a mustard prodrug/carboxypeptidase G2 combination.
Marais R; Spooner RA; Light Y; Martin J; Springer CJ
Cancer Res; 1996 Oct; 56(20):4735-42. PubMed ID: 8840992
[TBL] [Abstract][Full Text] [Related]
6. Studies of Metabolism Using (13)C MRS of Hyperpolarized Probes.
Chaumeil MM; Najac C; Ronen SM
Methods Enzymol; 2015; 561():1-71. PubMed ID: 26358901
[TBL] [Abstract][Full Text] [Related]
7. Novel fluorinated prodrugs for activation by carboxypeptidase G2 showing good in vivo antitumor activity in gene-directed enzyme prodrug therapy.
Davies LC; Friedlos F; Hedley D; Martin J; Ogilvie LM; Scanlon IJ; Springer CJ
J Med Chem; 2005 Aug; 48(16):5321-8. PubMed ID: 16078849
[TBL] [Abstract][Full Text] [Related]
8. Novel inhibitors of carboxypeptidase G2 (CPG2): potential use in antibody-directed enzyme prodrug therapy.
Khan TH; Eno-Amooquaye EA; Searle F; Browne PJ; Osborn HM; Burke PJ
J Med Chem; 1999 Mar; 42(6):951-6. PubMed ID: 10090777
[TBL] [Abstract][Full Text] [Related]
9. Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2.
Schepelmann S; Ogilvie LM; Hedley D; Friedlos F; Martin J; Scanlon I; Chen P; Marais R; Springer CJ
Cancer Res; 2007 May; 67(10):4949-55. PubMed ID: 17510425
[TBL] [Abstract][Full Text] [Related]
10. Soluble expression, purification and functional characterisation of carboxypeptidase G2 and its individual domains.
Jeyaharan D; Aston P; Garcia-Perez A; Schouten J; Davis P; Dixon AM
Protein Expr Purif; 2016 Nov; 127():44-52. PubMed ID: 27374188
[TBL] [Abstract][Full Text] [Related]
11. Self-immolative nitrogen mustard prodrugs for suicide gene therapy.
Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Spooner R; Davies L; Marais R; Springer CJ
J Med Chem; 1998 Dec; 41(26):5297-309. PubMed ID: 9857097
[TBL] [Abstract][Full Text] [Related]
12. Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.
Niculescu-Duvaz I; Scanlon I; Niculescu-Duvaz D; Friedlos F; Martin J; Marais R; Springer CJ
J Med Chem; 2004 May; 47(10):2651-8. PubMed ID: 15115406
[TBL] [Abstract][Full Text] [Related]
13. Self-immolative nitrogen mustards prodrugs cleavable by carboxypeptidase G2 (CPG2) showing large cytotoxicity differentials in GDEPT.
Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Lehouritis P; Marais R; Springer CJ
J Med Chem; 2003 Apr; 46(9):1690-705. PubMed ID: 12699387
[TBL] [Abstract][Full Text] [Related]
14. Biphasically Modulating the Activity of Carboxypeptidase G2 with Ultrasound.
Ma W; Zhang Y; Zheng X; Yu T
Cell Physiol Biochem; 2017; 42(4):1614-1622. PubMed ID: 28738357
[TBL] [Abstract][Full Text] [Related]
15. Dynamic nuclear polarization and optimal control spatial-selective 13C MRI and MRS.
Vinding MS; Laustsen C; Maximov II; Søgaard LV; Ardenkjaer-Larsen JH; Nielsen NC
J Magn Reson; 2013 Feb; 227():57-61. PubMed ID: 23298857
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of the Carboxypeptidase G2 Catalytic Site and Design of New Inhibitors for Cancer Therapy.
Jeyaharan D; Brackstone C; Schouten J; Davis P; Dixon AM
Chembiochem; 2018 Sep; 19(18):1959-1968. PubMed ID: 29968955
[TBL] [Abstract][Full Text] [Related]
17. Hyperpolarized (13)C Magnetic Resonance and Its Use in Metabolic Assessment of Cultured Cells and Perfused Organs.
Lumata L; Yang C; Ragavan M; Carpenter N; DeBerardinis RJ; Merritt ME
Methods Enzymol; 2015; 561():73-106. PubMed ID: 26358902
[TBL] [Abstract][Full Text] [Related]
18. Nanosecond electric pulses deprive zinc ions of carboxypeptidase G2.
Yu T; Fu X
Bioelectrochemistry; 2015 Feb; 101():42-5. PubMed ID: 25049063
[TBL] [Abstract][Full Text] [Related]
19. Production of Long-Acting CNGRC-CPG2 Fusion Proteins: New Derivatives to Overcome Drug Immunogenicity of Ligand-Directed Enzyme Prodrug Therapy for Targeted Cancer Treatment.
Al-Mansoori L; Al Qahtani AD; Elsinga P; Goda SK
Technol Cancer Res Treat; 2021; 20():15330338211057371. PubMed ID: 34802309
[No Abstract] [Full Text] [Related]
20. Engineering carboxypeptidase G2 circular permutations for the design of an autoinhibited enzyme.
Yachnin BJ; Khare SD
Protein Eng Des Sel; 2017 Apr; 30(4):321-331. PubMed ID: 28160000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
